2,4-thiazolidinedione has been researched along with Neoplasm Metastasis in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Excerpt | Relevance | Reference |
---|---|---|
"Type-II Endometrial Cancer (EMC) is one of the most common types of gynaecological cancer affecting more than 2." | 1.51 | Possible role of Thiazolidinedione in the management of Type-II Endometrial Cancer. ( Ammu, VVVRK; Chintamaneni, PK; Garikapati, KK; Krishnamurthy, PT; Pindiprolu, SKSS, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garikapati, KK | 1 |
Ammu, VVVRK | 1 |
Krishnamurthy, PT | 1 |
Chintamaneni, PK | 1 |
Pindiprolu, SKSS | 1 |
Panigrahy, D | 1 |
Singer, S | 1 |
Shen, LQ | 1 |
Butterfield, CE | 1 |
Freedman, DA | 1 |
Chen, EJ | 1 |
Moses, MA | 1 |
Kilroy, S | 1 |
Duensing, S | 1 |
Fletcher, C | 1 |
Fletcher, JA | 1 |
Hlatky, L | 1 |
Hahnfeldt, P | 1 |
Folkman, J | 1 |
Kaipainen, A | 1 |
Yoshizumi, T | 1 |
Ohta, T | 1 |
Ninomiya, I | 1 |
Terada, I | 1 |
Fushida, S | 1 |
Fujimura, T | 1 |
Nishimura, G | 1 |
Shimizu, K | 1 |
Yi, S | 1 |
Miwa, K | 1 |
3 other studies available for 2,4-thiazolidinedione and Neoplasm Metastasis
Article | Year |
---|---|
Possible role of Thiazolidinedione in the management of Type-II Endometrial Cancer.
Topics: Adipokines; Adiponectin; Animals; Cell Proliferation; Endometrial Neoplasms; Female; Gene Expression | 2019 |
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cattle; Fibroblast Growth Factor 2; Humans; | 2002 |
Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cadherins; Cell Cycle; Cell Cycle Proteins; Cell Diffe | 2004 |